{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:26:32Z","timestamp":1787167592432,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bpa.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:27:18Z","timestamp":1779380838000},"page":"74-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the trigger and the effector: The dual role of extracorporeal blood purification therapy in septic immune dysregulation"],"prefix":"10.1016","volume":"40","author":[{"given":"Gabriella","family":"Bottari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Pota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Alessandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpa.2026.05.002_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.bpa.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib3","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026","author":"Prescott","year":"2026","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-024-05220-7","article-title":"Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives","volume":"28","author":"Bottari","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000533468","article-title":"Blood purification hemodialysis-guidelines nomenclature of extracorporeal blood purification therapies for acute indications: the nomenclature standardization conference on behalf of the nomenclature standardization faculty","volume":"53","author":"Ostermann","year":"2024","journal-title":"Blood Purif"},{"key":"10.1016\/j.bpa.2026.05.002_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.bpa.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00134-022-06793-z","article-title":"Plasma exchange in the intensive care unit: a narrative review on behalf of the Nine-I investigators","volume":"48","author":"Bauer","year":"2022","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.bpa.2026.05.002_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1525-1594.2003.07289.x","article-title":"Interpreting the mechanism of continuous renal replacement therapyin sepsis: the peak concentartion hypothesis","volume":"27","author":"Ronco","year":"2003","journal-title":"Artif Organs"},{"key":"10.1016\/j.bpa.2026.05.002_bib9","volume":"vol. 31","author":"Cruz","year":"2008"},{"key":"10.1016\/j.bpa.2026.05.002_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/ALN.0b013e318256f0c0","article-title":"High-volume hemofiltration in the intensive care unit: a blood purification therapy","volume":"116","author":"Rimmel\u00e9","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bpa.2026.05.002_bib11","series-title":"Hemofiltration-for-Cytokine-Driven-Illnesses-the-Mediator-Delivery-Hypothesis","author":"Di","year":"2005"},{"key":"10.1016\/j.bpa.2026.05.002_bib12","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0272-6386(97)90541-2","article-title":"Mediator removal with CRRT: complement and cytokines","volume":"30","author":"Silvester","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bpa.2026.05.002_bib13","unstructured":"Ankawi, G.; Neri, M.; Zhang, J.; Breglia, A.; Ricci, Z.; Ronco, C. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls., doi:10.1186\/s13054-018-2181-z.."},{"key":"10.1016\/j.bpa.2026.05.002_bib14","unstructured":"Honore, P.M.; Hoste, E.; Moln\u00e1r, Z.; Jacobs, R.; Joannes-Boyau, O.; Malbrain, M.L.N.G.; Forni, L.G. Cytokine removal in human septic shock: where are we and where are we going?, doi:10.1186\/s13613-019-0530-y.."},{"issue":"1","key":"10.1016\/j.bpa.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40635-025-00740-0","article-title":"Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future","volume":"13","author":"Waalders","year":"2025","journal-title":"Inten Care Med Exper"},{"key":"10.1016\/j.bpa.2026.05.002_bib16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.1989.31","article-title":"Functional changes of monocytes due to dialysis membranes","volume":"35","author":"Roccatello","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.bpa.2026.05.002_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092260","article-title":"The end of \u201cOne Size Fits All\u201d sepsis therapies: toward an individualized approach","volume":"10","author":"Vincent","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bpa.2026.05.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104318","article-title":"Current sepsis therapeutics","volume":"86","author":"Vincent","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bpa.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00134-016-4471-8","article-title":"Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? We are not sure","volume":"42","author":"Gattinoni","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib20","article-title":"Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial","volume":"3","author":"Leventogiannis","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2025.24175","article-title":"Precision immunotherapy to improve sepsis outcomes: the ImmunoSep randomized clinical trial","volume":"335","author":"Giamarellos-Bourboulis","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.bpa.2026.05.002_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4103\/jfmpc.jfmpc_963_24","article-title":"Neutrophil-to-Lymphocyte ratio in predicting mortality in sepsis and its correlation with sofa score and C-Reactive protein values","volume":"14","author":"Nayak","year":"2025","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70561","article-title":"Sepsis endotypes defined by lymphocyte thresholds and inflammation inform precision immunomodulation","volume":"7","author":"Sun","year":"2026","journal-title":"MedComm"},{"key":"10.1016\/j.bpa.2026.05.002_bib24","article-title":"Bioengineered extracellular vesicles: future of precision medicine for sepsis","volume":"11","author":"Areny-Balaguer\u00f3","year":"2023","journal-title":"Inten Care Med Exper"},{"key":"10.1016\/j.bpa.2026.05.002_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpa.2026.05.002_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1130214","article-title":"Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis","volume":"14","author":"Joshi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpa.2026.05.002_bib27","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00134-025-08110-w","article-title":"Monocyte HLA-DR expression in septic shock patients: insights from a 20-Year real-world cohort of 1023 cases","volume":"51","author":"Monneret","year":"2025","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.bpa.2026.05.002_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.bpa.2026.05.002_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpa.2026.05.002_bib30","unstructured":"Chen, Z.; Zhang, H.; Qu, M.; Nan, K.; Cao, H.; Cata, J.P.; Chen, W.; Miao, C. Review: the emerging role of neutrophil extracellular traps in sepsis and sepsis-associated thrombosis., doi:10.3389\/fcimb.2021.653228.."},{"key":"10.1016\/j.bpa.2026.05.002_bib31","series-title":"The dual role of neutrophil extracellular traps (NETs) in sepsis and ischemia-reperfusion injury: comparative analysis across murine models","author":"Kiwit","year":"2024"},{"key":"10.1016\/j.bpa.2026.05.002_bib32","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.3390\/ijms22168882","article-title":"Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification","volume":"22","author":"Moriyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpa.2026.05.002_bib33","series-title":"Molecular sciences toll-like receptors in acute kidney injury","author":"V\u00e1zquez-Carballo","year":"2021"},{"key":"10.1016\/j.bpa.2026.05.002_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/ijms21020379","article-title":"Recent advances in lipopolysaccharide recognition systems","volume":"21","author":"Mazgaeen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpa.2026.05.002_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Series: fresh perspectives from emerging experts pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bpa.2026.05.002_bib36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","article-title":"Innate immunity to intracellular LPS","volume":"20","author":"Rathinam","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bpa.2026.05.002_bib37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s002680020028","article-title":"Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator Inhibitor-1 activities in septic patients","volume":"25","author":"Tani","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.bpa.2026.05.002_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjsurg.2003.12.067","article-title":"Modulation of human leukocyte Antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-Immobilized fiber","volume":"188","author":"Ono","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.bpa.2026.05.002_bib39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jcrc.2010.11.010","article-title":"Ichi suppression of high-mobility group Box-1 and receptor for advanced glycation end-product axis by polymyxin B\u2013Immobilized fiber hemoperfusion in septic shock patients","volume":"26","author":"Nakamura","year":"2011","journal-title":"J Crit Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jss.2009.11.708","article-title":"HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP","volume":"171","author":"Ueno","year":"2011","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.bpa.2026.05.002_bib41","first-page":"405","article-title":"Effects of hemoperfusion with an immobilized Polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis","volume":"76","year":"2010","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.bpa.2026.05.002_bib42","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s001340050761","article-title":"Changes in plasma erythropoietin and Interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-Immobilized fiber","volume":"24","author":"Nakamura","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1744-9987.2006.00407.x","article-title":"Hemoperfusion with an immobilized polymyxin B fiber column improves tissue oxygen metabolism","volume":"10","author":"Kushi","year":"2006","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.bpa.2026.05.002_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/SHK.0b013e3181e14ca0","article-title":"Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock","volume":"34","author":"Kumagai","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.bpa.2026.05.002_bib45","first-page":"262","article-title":"Removal of increased circulating CD4+CD25+Foxp3 + regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-Immobilized fibers","volume":"153","author":"Ono","year":"2013","journal-title":"Surgery (United States)"},{"key":"10.1016\/j.bpa.2026.05.002_bib46","article-title":"Safety summary of the selective cytopheretic device: a review of safety data across multiple clinical trials in ICU patients with acute kidney injury and multiple organ failure","volume":"5","author":"Humes","year":"2023","journal-title":"Crit Care Explor"},{"issue":"1","key":"10.1016\/j.bpa.2026.05.002_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63121-9","article-title":"Immunomodulatory effects of a cell processing device to ameliorate dysregulated hyperinflammatory disease states","volume":"14","author":"Westover","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpa.2026.05.002_bib48","first-page":"628","article-title":"The impact of the selective cytopheretic device on neutrophil-to-lymphocyte ratios and hematological parameters in acute kidney injury: a pooled analysis","volume":"149","author":"Iyer","year":"2025","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.bpa.2026.05.002_bib49","article-title":"Extracorporeal immunomodulation treatment and clinical outcomes in ICU COVID-19 patients","volume":"4","author":"Yessayan","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.bpa.2026.05.002_bib50","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.healun.2023.06.011","article-title":"Nothing but NETs: cytokine adsorption correlates with lower circulating nucleosomes and is associated with decreased primary graft dysfunction","volume":"42","author":"Lindstedt","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.bpa.2026.05.002_bib51","unstructured":"Boffini, M.; Marro, M.; Simonato, E.; Scalini, F.; Costamagna, A.; Fanelli, V.; Barbero, C.; Solidoro, P.; Brazzi, L.; Rinaldi, M. Cytokines removal during Ex-Vivo lung perfusion: initial clinical experience., doi:10.3389\/ti.2023.10777.."},{"key":"10.1016\/j.bpa.2026.05.002_bib52","unstructured":"Bottari, G.; Cecchetti, C.; Serpe, C.; Grimaldi, D.; Taccone, F.S. CORRESPONDENCE open access potential correlation between hemodynamic improvement and an immune-modulation effect in pediatric patients with septic shock treated with renal replacement therapy and CytoSorb \u00ae : an insight from the PedCyto study., doi:10.1186\/s13054-024-04802-9.."},{"key":"10.1016\/j.bpa.2026.05.002_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000550150","article-title":"An expert interpretation on the evolution of OXiris\u00ae-Focused consensus statements: from Europe to the Asia-Pacific (2019-2024)","volume":"55","author":"Zhang","year":"2025","journal-title":"Blood Purif"},{"key":"10.1016\/j.bpa.2026.05.002_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299757","article-title":"Comparative analyses of adsorbed circulating proteins in the PMMA and PES hemodiafilters in patients on predilution online hemodiafiltration","volume":"19","author":"Islam","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bpa.2026.05.002_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13613-019-0530-y","article-title":"Cytokine removal in human septic shock: where are we and where are we going?","volume":"9","author":"Honore","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib56","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00134-022-06810-1","article-title":"Hemoperfusion in the intensive care unit","volume":"48","author":"Ricci","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04009-w","article-title":"Hemoperfusion: technical aspects and state of the art","volume":"26","author":"Ronco","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib58","unstructured":"Zheng, F.; Wang, Y.; Zhou, W.; Zhang, J.; Lu, M.; Pan, N.; He, J.; Zhang, Q.; Cao, L.; Wu, J.; et al. Continuous renal replacement therapy with adsorbing filter OXiris in the treatment of sepsis associated acute kidney injury: a single-center retrospective observational study., doi:10.1186\/s12882-024-03897-0.."},{"key":"10.1016\/j.bpa.2026.05.002_bib59","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/03913988221107947","article-title":"Effect of CRRT with OXiris filter on hemodynamic instability in surgical septic shock with AKI: a pilot randomized controlled trial","volume":"45","author":"Feng","year":"2022","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.bpa.2026.05.002_bib60","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.3390\/jcm14196931","article-title":"Is there a rationale for haemoadsorption with combined use of CytoSorb\u00ae and oxiris\u00ae in patients with underlying viral infection and secondary bacterial sepsis?","volume":"14","author":"Wrzosek","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib61","article-title":"Application of OXiris-Continuous hemofiltration adsorption in patients with sepsis and septic shock: a single-centre experience in China","volume":"10","author":"Zhou","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.bpa.2026.05.002_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s40001-021-00614-7","article-title":"Observational case series: six neurosurgical patients with septic shock demonstrating clinical improvement after a combination of standard care and blood purification","volume":"26","author":"Burov","year":"2021","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.bpa.2026.05.002_bib63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13613-023-01224-8","article-title":"Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high levels of endotoxemia: the ENDoX bicentric, randomized, controlled trial","volume":"13","author":"David","year":"2023","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib64","first-page":"1","article-title":"Interleukin-6 removal and clinical effects of oxiris: a systematic review and meta-analysis","author":"Ulsamer","year":"2025","journal-title":"Blood Purif"},{"key":"10.1016\/j.bpa.2026.05.002_bib65","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s40001-023-01184-6","article-title":"Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial","volume":"28","author":"Nakamura","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.bpa.2026.05.002_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154844","article-title":"Outcomes of extracorporeal blood purification with OXiris\u00ae membrane in critically ill patients: a systematic review and meta-analysis","volume":"83","author":"Siew","year":"2024","journal-title":"J Crit Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40560-025-00835-6","article-title":"TIGRIS and EUPHRATES eventually join and provide new evidence: a narrative review of the polymyxin B hemoperfusion","volume":"13","author":"Iba","year":"2025","journal-title":"J Intensiv Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib68","series-title":"The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial","author":"Sch\u00e4 dler","year":"2017"},{"key":"10.1016\/j.bpa.2026.05.002_bib69","first-page":"122","article-title":"Hemoperfusion with the HA330\/HA380 cartridge in intensive care settings: a state-of-the-art review","volume":"54","author":"Li","year":"2025","journal-title":"Blood Purif"},{"key":"10.1016\/j.bpa.2026.05.002_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13054-022-04044-7","article-title":"Safety and efficacy of the seraph\u00ae 100 microbind\u00ae affinity blood filter to remove bacteria from the blood stream: results of the first in human study","volume":"26","author":"Eden","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.bpa.2026.05.002_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283304","article-title":"Staphylococcus aureus binding to seraph\u00ae 100 microbind\u00ae affinity filter: effects of surface protein expression and treatment duration","volume":"18","author":"Seffer","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bpa.2026.05.002_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283304","article-title":"Staphylococcus aureus binding to seraph\u00ae 100 microbind\u00ae affinity filter: effects of surface protein expression and treatment duration","volume":"18","author":"Seffer","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bpa.2026.05.002_bib73","doi-asserted-by":"crossref","DOI":"10.1053\/j.jvca.2026.01.040","article-title":"Venoarterial extracorporeal membrane oxygenation and seraph 100 for meningococcemia septic shock and Purpura fulminans","author":"Behaine","year":"2026","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bpa.2026.05.002_bib74","doi-asserted-by":"crossref","unstructured":"Schmidt, J.J.; Nicolae Borchina, D.; Van\u2019t Klooster, M.; Bulhan-Soki, K.; Okioma, R.; Herbst, L.; Sandoval Rodr\u00edguez, D.; Premu\u017ei\u0107premu\u017ei\u0107, V.; B\u00fcttner, S.; Bader, B.; et al. Interim analysis of the COSA (COVID-19 patients treated with the seraph R 100 microbind R affinity filter) registry., doi:10.1093\/ndt\/gfab347.","DOI":"10.1093\/ndt\/gfab347"},{"key":"10.1016\/j.bpa.2026.05.002_bib75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00467-023-06097-4","article-title":"Use of the seraph\u00ae 100 microbind\u00ae affinity blood filter in an adolescent patient with disseminated adenoviral disease","volume":"39","author":"Li","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.bpa.2026.05.002_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s40635-025-00725-z","article-title":"The effect of therapeutic plasma exchange on the inflammatory response in septic shock: a secondary analysis of the EXCHANGE-1 trial","volume":"13","author":"Sauer","year":"2025","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.bpa.2026.05.002_bib77","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07300-5","article-title":"EXCHANGE-2: investigating the efficacy of Add-on plasma exchange as an adjunctive strategy against septic Shock\u2014A study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial","volume":"24","author":"David","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.bpa.2026.05.002_bib78","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00134-020-06339-1","article-title":"Adjuvant therapeutic plasma exchange in septic shock","volume":"47","author":"David","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bpa.2026.05.002_bib79","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.actbio.2025.11.016","article-title":"Nanobody-based high-performance multitarget immunosorbents protect against sepsis by concurrently adsorbing endotoxins and inflammatory cytokines","volume":"209","author":"Wang","year":"2026","journal-title":"Acta Biomater"},{"key":"10.1016\/j.bpa.2026.05.002_bib80","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.actbio.2023.09.050","article-title":"Nanobody-functionalized conduit with Built-in static mixer for specific elimination of cytokines in hemoperfusion","volume":"172","author":"Yao","year":"2023","journal-title":"Acta Biomater"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1753374026000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1753374026000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:20:25Z","timestamp":1785874825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1753374026000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1753374026000043"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2026.05.002","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the trigger and the effector: The dual role of extracorporeal blood purification therapy in septic immune dysregulation","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}